| Announce Date | 10/31/2025 |
| EPS Normalized Actual | $1.33 (Beat by $0.09) |
| EPS GAAP Actual | $1.33 (Beat by $0.09) |
| Revenue Actual | $10.346B |
| Revenue Surprise | Beat by $10346M |
| Announce Date | 12/31/1969 (Pre-Market) |
| EPS Normalized Estimate | $ |
| EPS GAAP Estimate | $ |
| Revenue Estimate | $0B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2028 | 9.83944 | 5.88 | 9.69436 | 10.11553 | 5 |
| Dec 2027 | 8.84051 | 6.54 | 8.71016 | 9.08857 | 4 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 1.07 | 1.07 | 10.346B | -0.16% | 10346M |
| FQ2 2025 (Jun 2025) | 1.33 | 1.33 | 10.631B | -3.05% | 10631M |
| FQ1 2025 (Mar 2025) | 0 | 0 | 10.069B | -8.46% | 10069M |
| FQ4 2024 (Dec 2024) | 0.69 | 0.69 | 10.3281B | -4.02% | 10328.1M |
| FQ3 2024 (Sep 2024) | 1.7 | 1.7 | 10.3627B | -3.14% | 10362.7M |
| FQ2 2024 (Jun 2024) | 1.09 | 1.09 | 10.9557B | -0.24% | 10955.7M |
| FQ1 2024 (Mar 2024) | 0.0312 | 0.0312 | 10.921B | 2.27% | 10921M |
| FQ4 2023 (Dec 2023) | 0.97 | 0.97 | 10.7429B | 100% | 10742.9M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 1.98354 | -- | 1.94939 | 2.0187 | 1 |
| FQ3 2027 (Sep 2027) | 1.65097 | -- | 1.62254 | 1.68024 | 1 |
| FQ2 2027 (Jun 2027) | 1.65446 | -- | 1.62597 | 1.68379 | 1 |
| FQ1 2027 (Mar 2027) | 1.51108 | -- | 1.48506 | 1.53787 | 1 |
| FQ4 2026 (Oct 2026) | 2.25431 | -- | 2.19532 | 2.32303 | 0 |
| FQ3 2026 (Jul 2026) | 2.133 | 49.84 | 2.07718 | 2.19802 | 0 |
| FQ2 2026 (Jun 2026) | 1.49407 | 10.98 | 1.46834 | 1.52056 | 1 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 11.08B | -- | 10.94B | 11.24B | 2 |
| FQ3 2027 (Sep 2027) | 10.99B | -- | 10.84B | 11.14B | 2 |
| FQ2 2027 (Jun 2027) | 11.11B | -- | 10.96B | 11.26B | 2 |
| FQ1 2027 (Mar 2027) | 10.76B | -- | 10.61B | 10.9B | 2 |
| FQ4 2026 (Oct 2026) | 12.07B | -- | 11.83B | 12.36B | 1 |
| FQ3 2026 (Jul 2026) | 12.57B | 17.67 | 12.31B | 12.86B | 1 |
| FQ2 2026 (Jun 2026) | 10.8B | 1.53 | 10.65B | 10.94B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
7
EPS # of Misses
0
EPS # of in-lines
1
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 1.07 | 1.07 | 100% | |
| FQ2 2025 (Jun 2025) | 1.33 | 1.33 | 100% | |
| FQ1 2025 (Mar 2025) | 0 | 0 | NAN% | |
| FQ4 2024 (Dec 2024) | 0.69 | 0.69 | 100% | |
| FQ3 2024 (Sep 2024) | 1.7 | 1.7 | 100% | |
| FQ2 2024 (Jun 2024) | 1.09 | 1.09 | 100% | |
| FQ1 2024 (Mar 2024) | 0.0312 | 0.0312 | 100% | |
| FQ4 2023 (Dec 2023) | 0.97 | 0.97 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0B | $10.35B | $10346M | 100% |
| FQ2 2025 (Jun 2025) | $0B | $10.63B | $10631M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $10.07B | $10069M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $10.33B | $10328.1M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $10.36B | $10362.7M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $10.96B | $10955.7M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $10.92B | $10921M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $10.74B | $10742.9M | 100% |